In 2021, the FDA approved Wegovywhich is also semaglutidefor chronic weight management in adults who have obesity (defined as a body mass index of 30 or greater) or adults who have excess weight (defined as a body mass index of 27) and at least one weight-related condition like high cholesterol, high blood pressure, or type 2 diabetes
While this represents a small percentage of users, the consequences can be severe and sometimes permanent.Dr
[3] That reversibility is a crucial, often-omitted caveat: tesamorelins effect is a maintained pharmacological state, not a one-time fix. We discuss the visceral-fat data and its limits further in our reference on tesamorelins visceral-fat effects and safety profile
That change, while it sounds simple, has enormous implications for long-term adherence to any eating plan
Semaglutide GLP-1 Injections: Before and After Results at Vive Ageless Weight Loss Center How much weight can I lose in a month on semaglutide GLP-1